Sentences with phrase «higher after transplant»

Not exact matches

Chris Klug, founder of the Chris Klug Foundation and affiliated high school and college outreach program Donor Dudes, shows just how personal nonprofit work can get: Klug is the only Olympian to ever medal after having an organ transplant.

In the early 2000s, Johns Hopkins scientists Leo Luznik and Ephraim Fuchs found that giving patients high doses of cyclophosphamide — a drug derived from nitrogen mustard and used to treat blood cancers — three days after bone marrow transplant successfully thwarts acute and chronic GVHD.

Patients receiving standard immunosuppressive drugs after transplant, as opposed to high - dose cyclophosphamide, have slower recovery of regulatory T - cells in their blood, adds Kanakry.

The study, «Lenalidomide (LEN) maintenance (MNTC) after high - dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta - analysis (MA) of overall survival (OS),» is ASCO 2016 abstract no. 8001 and will be discussed during the Hematologic Malignancies — Plasma Cell Dyscrasia oral abstract session Friday, June 3.

Researchers at the Scripps Institution of Oceanography in San Diego, California, suggest that high levels of carbon monoxide in the seals» blood has a protective effect — echoing laboratory research on rats and mice that has found the gas has anti-inflammatory properties and can lead to better outcomes after organ transplant.

«Here's a person who has received a precious organ in a liver or a heart, after going through high risk transplant surgery and the mental anguish that goes along with that,» says Thakar.

Four weeks after transplanting these cells into the kidney cavities of mice with a form of kidney anaemia, the treated animals had blood EPO levels 20 times higher than those in controls (Science Translational Medicine, doi.org/cdmx).

Brentuximab vedotin was previously approved by the FDA to treat cHL after relapse, cHL after stem cell transplant when a patient is at a high risk of relapse or progression, systemic anaplastic large cell lymphoma (ALCL) after failure of other treatment, and primary cutaneous ALCL after failure of other treatment.